on 20 Nov 2024
Last Applicant/ Owned by
Vertex Pharmaceuticals Incorporated
50 Northern AvenueBoston MA 02210
US
Serial Number
2363638 filed on 15th Oct 2024
Vienna Information
24 . 17 . 1
Punctuation marksSignes de ponctuation
24 . 17 . 2
DotsPoints
25 . 7 . 1
Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés
25 . 7 . 6
Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses
25 . 7 . 7
Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points
26 . 1 . 1
CirclesCercles
26 . 1 . 6
Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
Trademark usage description
pharmaceutical preparations for the treatment of cystic fibrosis.12
2363638
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 257 on 21st Nov 2024 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 20th Nov 2024 | Created |
Submitted for opposition 31 on 20th Nov 2024 | Formalized |
Submitted for opposition 30 on 15th Oct 2024 | Filed |
Submitted for opposition 228 on 15th Oct 2024 | International Registration |